Staar Surgical Co (NASDAQ:STAA) price on Thursday, February 27, rose 3.51% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $17.69.
A look at the stock’s price movement, the close in the last trading session was $17.09. Turning to its 52-week performance, $52.68 and $13.50 were the 52-week high and 52-week low respectively. Overall, STAA moved -29.21% over the past month.
Staar Surgical Co’s market cap currently stands at around $872.57 million, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 40.33M for the company’s revenue for the quarter, with a low and high estimate of 39.74M and 41.55M respectively. The average forecast suggests down to a -47.87% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 260.75M, representing a -16.93% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that STAA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
13 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 11 recommend STAA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
STAA’s current price about -9.55% and -20.03% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.51, while 7-day volatility ratio is 6.64% and 6.97% in the 30-day chart. Further, Staar Surgical Co (STAA) has a beta value of 0.67, and an average true range (ATR) of 1.46. Analysts have given the company’s stock an average 52-week price target of $48, forecast between a low of $45.03 and high of $85. Looking at the price targets, the low is -154.55% off current price level while to achieve the yearly target high, price needs to move -380.5%. Nonetheless, investors will most likely welcome a -171.34% jump to $48 which is the analysts’ median price.
If we refocus on Staar Surgical Co (NASDAQ:STAA), historical trading data shows that trading volumes averaged 868.29K over the past 3 months. The company’s latest data on shares outstanding shows there are 49.29 million shares.
The 0.63% of Staar Surgical Co’s shares are in the hands of company insiders while institutional holders own 99.53% of the company’s shares. Current price change has pushed the stock -27.17% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the STAA stock continues to rise going into the next quarter.
